All In Biotech

Drug Trial Radar · NCT00641745

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jun 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 629 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

629

Actual

Start

Mar 2008

Primary completion

Jul 2010

Study completion Jul 2010

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Mar 24, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder

Interventions

  • Lurasidone HClDrug

    40 - 120mg per day

  • RisperidoneDrug

    Risperidone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events.Time frame: 12 months

Locations

73 sites in 8 countries. Site status is shown where the registry gives one.

  • K&S Professional Research Services LLC

    Little Rock, Arkansas

  • Woodland International Research Group, LLC

    Little Rock, Arkansas

  • South Coast Clinical Trials, Inc.

    Anaheim, California

  • Comprehensive NeuroScience, Inc. - Cerritos

    Cerritos, California

  • Clinical Innovations Inc.

    Costa Mesa, California

  • Collaborative Neuroscience Network Inc

    Garden Grove, California

  • University of Southern California

    Los Angeles, California

  • Excell Research

    Oceanside, California

  • University of California at Irvine Medical Center

    Orange, California

  • Pasadena Research Institute

    Pasadena, California

  • CNRI-Los Angeles, LLC

    Pico Rivera, California

  • Clinical Innovations Inc.

    Riverside, California

  • CNRI-San Diego LLC

    San Diego, California

  • UCSD, Outpatient Psychiatric Services

    San Diego, California

  • Clinical Innovations Inc.

    Santa Ana, California

  • Collaborative Neuroscience Network Inc

    Torrance, California

  • Comprehensive NeuroScience, Inc.

    Washington D.C., District of Columbia

  • Fidelity Clinical Research Inc., c/o Segal Institute for Clinical Research

    North Miami, Florida

  • Fidelity Clinical Research Inc.

    North Miami, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Northlake Medical Research Center

    Tucker, Georgia

  • Alexian Brothers Medical Center

    Hoffman Estates, Illinois

  • Lake Charles Clinical Trials

    Lake Charles, Louisiana

  • Sheppard Pratt Health System

    Baltimore, Maryland

  • Precise Research Center

    Flowood, Mississippi

  • St. Charles Psychiatric Associates - Midwest Research

    Saint Charles, Missouri

  • St. Louis Clinical Trials

    St Louis, Missouri

  • Creighton University

    Omaha, Nebraska

  • CRI Worldwide

    Willingboro, New Jersey

  • SUNY Downstate University

    Brooklyn, New York

  • Neurobehavioral Research Inc.

    Cedarhurst, New York

  • Manhattan Psychiatric Center

    New York, New York

  • Social Psychiatry Research Institute

    New York, New York

  • University of North Carolina at Chapel Hill

    Raleigh, North Carolina

  • Keystone Clinical Studies, LLC

    Norristown, Pennsylvania

  • CRI Worldwide

    Philadelphia, Pennsylvania

  • Research Strategies of Memphis LLC

    Memphis, Tennessee

  • Community Clinical Research, Inc.

    Austin, Texas

  • Pillar Clinical Research LLC

    Dallas, Texas

  • Claghorn-Lesem Research Clinic, Inc.

    Houston, Texas

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.